NEW DELHI: India may also consider continued reviews for the Covid-19 vaccine, particularly the Oxford-AstraZeneca-developed candidate that is already under accelerated review by the UK health regulator, to further accelerate the approval of vaccines in the current pandemic situation. An ongoing review will allow the regulator to examine the data …
Read More »